Xeris Pharmaceuticals

$4.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.70%) Today
-$0.03 (-0.71%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell XERS and other stocks, options, and ETFs commission-free!

About XERS

Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables.

CEO
Paul R. Edick
Employees
180
Headquarters
Chicago, Illinois
Founded
2005
Market Cap
290.40M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.65M
High Today
$4.29
Low Today
$4.16
Open Price
$4.24
Volume
816.06K
52 Week High
$7.94
52 Week Low
$1.56

XERS Earnings

-$1.23
-$0.82
-$0.41
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, Pre-Market

You May Also Like

PHUN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure